WSTAM
TMO icon

Wilbanks Smith & Thomas Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.21M Sell
2,088
-220
-10% -$123K 0.03% 209
2023
Q4 		$1.23M Buy
2,308
+18
+0.8% +$8.71K 0.04% 199
2023
Q3 		$1.16M Buy
2,290
+94
+4% +$50.1K 0.04% 208
2023
Q2 		$1.15M Buy
2,196
+82
+4% +$44.3K 0.04% 207
2023
Q1 		$1.22M Buy
2,114
+100
+5% +$56.4K 0.04% 197
2022
Q4 		$1.11M Sell
2,014
-287
-12% -$152K 0.04% 206
2022
Q3 		$1.17M Buy
2,301
+180
+8% +$101K 0.05% 201
2022
Q2 		$1.15M Buy
2,121
+294
+16% +$162K 0.05% 205
2022
Q1 		$998K Sell
1,827
-118
-6% -$67.8K 0.04% 219
2021
Q4 		$1.3M Sell
1,945
-20
-1% -$12.5K 0.05% 208
2021
Q3 		$1.12M Buy
1,965
+13
+0.7% +$7.13K 0.04% 214
2021
Q2 		$985K Hold
1,952
– – 0.04% 226
2021
Q1 		$891K Buy
1,952
+299
+18% +$143K 0.04% 221
2020
Q4 		$770K Sell
1,653
-51
-3% -$23.9K 0.04% 217
2020
Q3 		$752K Buy
1,704
+379
+29% +$157K 0.04% 198
2020
Q2 		$480K Sell
1,325
-462
-26% -$155K 0.03% 245
2020
Q1 		$507K Sell
1,787
-239
-12% -$75.4K 0.04% 217
2019
Q4 		$658K Sell
2,026
-31
-2% -$9.4K 0.04% 213
2019
Q3 		$599K Buy
2,057
+12
+0.6% +$3.44K 0.04% 205
2019
Q2 		$601K Sell
2,045
-13
-0.6% -$3.58K 0.04% 205
2019
Q1 		$563K Buy
2,058
+78
+4% +$19.4K 0.04% 223
2018
Q4 		$443K Sell
1,980
-312
-14% -$73.2K 0.03% 216
2018
Q3 		$559K Buy
2,292
+285
+14% +$65.6K 0.03% 224
2018
Q2 		$416K Buy
2,007
+182
+10% +$38.6K 0.03% 219
2018
Q1 		$377K Buy
1,825
+205
+13% +$43K 0.03% 227
2017
Q4 		$308K Sell
1,620
-37
-2% -$7.09K 0.02% 265
2017
Q3 		$314K Buy
1,657
+116
+8% +$21K 0.03% 246
2017
Q2 		$269K Buy
1,541
+185
+14% +$31.1K 0.02% 253
2017
Q1 		$208K Buy
+1,356
New +$207K 0.02% 303
2016
Q4 		– Sell
-1,360
Closed -$216K – 330
2016
Q3 		$216K Buy
+1,360
New +$210K 0.02% 262

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wilbanks Smith & Thomas Asset Management's TMO Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 9.5% in Q1 2024, selling an estimated $123K and leaving 2,088 shares worth $1.21M. The position accounts for 0.03% of the portfolio, ranked #209.

Wilbanks Smith & Thomas Asset Management first reported a position in TMO in Q3 2016 and has held it in 30 quarters since. The position peaked at $1.3M in Q4 2021. 2,528 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Wilbanks Smith & Thomas Asset Management held 2,088 shares of Thermo Fisher Scientific worth $1.21M as of Q1 2024.
  • Wilbanks Smith & Thomas Asset Management sold 220 Thermo Fisher Scientific shares in Q1 2024, an estimated $123K.
  • Thermo Fisher Scientific made up 0.03% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #209 holding.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Thermo Fisher Scientific in Q3 2016 and has held it in 30 quarters since.
  • Wilbanks Smith & Thomas Asset Management's Thermo Fisher Scientific position peaked at $1.3M in Q4 2021.
  • 2,528 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.